Pro Share Advisors LLC Intercept Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$14.28 - $19.53 $152,524 - $208,599	-10,681 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$12.99 - $20.47 $33,072 - $52,116	-2,546 Reduced 19.25%	10,681 $159,000
Q2 2021 Aug 13, 2021	BUY	$15.46 - $24.5 $26,745 - $42,385	1,730 Added 15.05%	13,227 $264,000
Q1 2021 May 14, 2021	BUY	$19.33 - $37.75 $12,815 - $25,028	663 Added 6.12%	11,497 $265,000
Q4 2020 Feb 09, 2021	BUY	$24.48 - $42.47 $57,307 - $99,422	2,341 Added 27.56%	10,834 $268,000
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $27,675 - $37,835	-708 Reduced 7.69%	8,493 $352,000
Q2 2020 Aug 03, 2020	BUY	$46.7 - $92.04 $129,218 - $254,674	2,767 Added 43.01%	9,201 $441,000
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $225,165 - $552,692	-4,657 Reduced 41.99%	6,434 $405,000
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $69,807 - $151,029	-1,217 Reduced 9.89%	11,091 $1.37 Million
Q3 2019 Nov 12, 2019	SELL	$58.69 - $80.46 $6,808 - $9,333	-116 Reduced 0.93%	12,308 $817,000
Q2 2019 Aug 13, 2019	SELL	$77.77 - $120.68 $70,537 - $109,456	-907 Reduced 6.8%	12,424 $989,000
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $29,936 - $39,341	326 Added 2.51%	13,331 $1.49 Million
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $214,646 - $316,402	-2,502 Reduced 16.13%	13,005 $1.31 Million
Q3 2018 Nov 14, 2018	SELL	$88.49 - $127.55 $27,343 - $39,412	-309 Reduced 1.95%	15,507 $1.96 Million
Q2 2018 Aug 13, 2018	BUY	$60.0 - $85.67 $223,440 - $319,035	3,724 Added 30.8%	15,816 $1.33 Million
Q1 2018 May 14, 2018	SELL	$52.72 - $67.25 $100,800 - $128,582	-1,912 Reduced 13.65%	12,092 $744,000
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $32,475 - $40,600	-558 Reduced 3.83%	14,004 $818,000
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $77,134 - $160,668	1,353 Added 10.24%	14,562 $845,000
Q2 2017 Aug 11, 2017	BUY	N/A	13,209	13,209 $1.6 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account